Table 8 Carotid-femoral pulse wave velocity.

From: Vitamin D Supplementation in Overweight/obese Asian Indian Women with Prediabetes Reduces Glycemic Measures and Truncal Subcutaneous Fat: A 78 Weeks Randomized Placebo-Controlled Trial (PREVENT-WIN Trial)

Variables Week 0 Week 52 Week 78 Overall p value
(Between the groups)
Overall Effect Size (95 %CI)
Using GEE Method
Intervention (n, 61) Placebo
(n, 60)
Intervention (n, 61) Placebo
(n, 60)
Intervention (n, 61) Placebo
(n, 60)
Pulse wave velocity (m/s) 7.1 ± 1.6 7.4 ± 2.2 6.8 ± 1.9 7.4 ± 2.2 6.8 ± 1.9 7.4 ± 2.2 0.55 −1.6 (−4.5, 9.1)
ASP (mmHg) 112.1 ± 5.1 112.3 ± 5.4 112.1 ± 2.8 111.8 ± 5.3 112.01 ± 2.8 111.8 ± 5.38 0.52 1.45 (−0.7,3.6)
APP (mmHg) 31.5 ± 3.4 30.6 ± 4.33 31.77 ± 3.4 30.6 ± 4.3 31.7 ± 3.4 30.6 ± 4.33 0.56 −1.9 (−6.5, 2.4)
Alx@HR75 (%) 29.0 ± 8.06 26.5 ± 8.99 29.5 ± 7.9 27.1 ± 8.3 29.5 ± 7.9 27.1 ± 8.3 0.34 −1.6 (−6.5, 2.6)
Ejection duration (%) 39.1 ± 3.6 39.4 ± 4.23 41.2 ± 12.5 39.5 ± 4.1 41.2 ± 5.3 41.4 ± 6.5 0.75 −0.9 (−1.5, 2.9)
SEVR (%) 136.4 ± 21.2 136 ± 23.2 135 ± 24.4 135.7 ± 22.8 135.1 ± 24.4 135.7 ± 22.8 0.96 −3.9 (−15.5, 7.5)
  1. Results are shown as mean ±  SD. p value < 0.05 statistically significant. Intention-to-treat analysis has been conducted. ASP, aortic systolic pressure (mm Hg); APP, aortic pulse pressure (mm Hg) Alx@75% HR, augmentation index @75% HR, SEVR, sub-endocardial viability ratio; GEE, generalized estimating equation. Further data provided in Supplementary Table 1.